Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CP✓SelectedUSD · CPMRNA vs CP performance historyLatest closeAs of+5.38%09/11
Stock and ETF performance explorer

MRNA vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+674.0%
CP return
+140.1%
Excess return
+533.9%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D+5.4%+0.4%+4.9%+5.3%
7D-1.1%-2.6%+1.5%-0.3%
30D+126.1%-3.7%+129.9%+128.7%
3M+190.0%+0.1%+189.9%+189.5%
6M+157.2%+7.8%+149.4%+151.0%
YTD+388.2%+21.7%+366.5%+360.1%
1Y+467.0%+18.6%+448.4%+438.4%
3Y+36.1%+17.5%+18.5%+30.4%
5Y-68.0%+35.4%-103.3%-69.3%
All+674.0%+140.1%+533.9%+551.2%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling